名臣健康(002919) - 2019 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2019 was ¥111,161,911.79, representing a decrease of 6.31% compared to ¥118,647,983.86 in the same period last year[7]. - Net profit attributable to shareholders was ¥8,568,054.69, down 1.46% from ¥8,695,399.38 year-on-year[7]. - The net profit after deducting non-recurring gains and losses increased by 11.22% to ¥8,573,706.00 from ¥7,709,063.14 in the previous year[7]. - Total operating revenue for Q1 2019 was CNY 111,161,911.79, a decrease of 6.3% compared to CNY 118,647,983.86 in Q4 2018[34]. - The company reported a net profit of CNY 7,660,369.50 for Q1 2019, compared to CNY 9,004,263.95 in Q4 2018, a decrease of 15.0%[34]. - Operating profit for Q1 2019 was CNY 11,281,732.54, down from CNY 12,788,978.59, reflecting a decline of 11.77%[40]. - Net profit for Q1 2019 was CNY 10,132,717.10, slightly down from CNY 10,181,215.54, indicating a decrease of 0.48%[41]. - Total profit for Q1 2019 was CNY 11,281,702.71, down from CNY 11,988,978.63, a decrease of 5.89%[40]. Cash Flow - The net cash flow from operating activities was -¥69,511,979.59, a decline of 18.05% compared to -¥58,882,518.04 in the same period last year[7]. - Cash flow from operating activities was CNY 107,789,022.49, compared to CNY 97,590,382.71 in the previous period, showing an increase of 10.93%[43]. - The total cash inflow from operating activities was 108,439,527.70 yuan, an increase from 99,677,092.04 yuan in the previous period, representing an increase of approximately 8.6%[44]. - The total cash outflow from operating activities was 177,951,507.29 yuan, compared to 158,559,610.08 yuan in the previous period, showing an increase of about 12.8%[44]. - The cash flow from financing activities was negative at -1,575,471.69 yuan, indicating outflows related to financing activities[49]. - The cash flow from operating activities showed a net outflow, highlighting challenges in maintaining positive cash flow from core operations[48]. - The company’s cash flow management strategies will be crucial in addressing the negative cash flow trends observed in the current reporting period[49]. Assets and Liabilities - Total assets at the end of the reporting period were ¥657,152,029.12, down 1.99% from ¥670,497,117.53 at the end of the previous year[7]. - The total current assets decreased to ¥574,727,889.66 from ¥620,180,344.24, reflecting a reduction in cash and cash equivalents[26]. - The total liabilities decreased to ¥657,152,029.12 from ¥698,664,409.44, indicating improved financial stability[26]. - The company's total assets decreased to CNY 631,845,784.50 from CNY 663,596,240.52 at the end of 2018, a decline of 4.8%[33]. - The total liabilities decreased to CNY 64,827,557.74 from CNY 106,710,730.86, a reduction of 39.2%[32]. - Current liabilities reached CNY 147,668,474.11, while total liabilities were CNY 147,768,474.11[52]. Shareholder Information - The company had a total of 11,150 common shareholders at the end of the reporting period[10]. - The largest shareholder, Chen Qinf, held 49.34% of the shares, amounting to 40,172,000 shares, with 15,500,000 shares pledged[10]. - The net assets attributable to shareholders increased by 2.43% to ¥559,463,990.02 from ¥546,215,363.96 at the end of the previous year[7]. - The total equity attributable to shareholders increased to CNY 567,018,226.76 from CNY 556,885,509.66, an increase of 1.9%[33]. Expenses and Costs - Total operating costs for Q1 2019 were CNY 103,501,542.29, down 5.3% from CNY 109,643,719.91 in Q4 2018[34]. - Research and development expenses increased to CNY 3,612,961.52, up 29.3% from CNY 2,794,180.67 in Q4 2018[34]. - The company reported a 32.48% decrease in taxes and surcharges to ¥403,316.15, due to a decline in value-added tax[14]. - The company paid 120,020,774.19 yuan for purchasing goods and services, which is an increase from 95,537,481.61 yuan in the previous period, reflecting a rise of about 25.6%[44]. Other Financial Metrics - The weighted average return on net assets was 1.54%, slightly down from 1.60% in the previous year[7]. - Basic and diluted earnings per share remained stable at CNY 0.11 for both periods[37]. - The company reported a foreign exchange loss of CNY 9,521.48, compared to a loss of CNY 19,250.00 in the previous year[40]. - The total comprehensive income for Q1 2019 was CNY 10,132,717.10, slightly lower than CNY 10,181,215.54 from the previous year[41].